source
- STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricingThe pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over access and pricing.STAT · 2mo ago↗ source
- STAT+: A new attack on AMA’s billing codesA key GOP lawmaker is broadening the party's efforts to combat health care fraud.STAT · 2mo ago↗ source
- BioNTech to scale down manufacturing, over 1,800 jobs on the lineBioNTech is making big cuts to its manufacturing footprint. The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff could be impacted by its planned downs…Endpoints · 2mo ago↗ source